Randomized Phase II Trial of Continuous Versus Standard Capecitabine in Advanced Breast Cancer.

Trial Profile

Randomized Phase II Trial of Continuous Versus Standard Capecitabine in Advanced Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2017

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Aug 2011 Planned end date changed from Jun 2011 to Dec 2011 as reported by ClinicalTrials.gov.
    • 17 Jun 2011 Status changed from recruiting to active, no longer recruiting.
    • 07 Jun 2011 Preliminary analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top